Impact of tucatinib on health-related quality of life (HRQoL) in patients with HER2+metastatic breast cancer (MBC) with and without brain metastases (BM)

Affiliation auteurs!!!! Error affiliation !!!!
TitreImpact of tucatinib on health-related quality of life (HRQoL) in patients with HER2+metastatic breast cancer (MBC) with and without brain metastases (BM)
Type de publicationJournal Article
Year of Publication2020
AuteursMueller V., Paplomata E., Hamilton E.P, Zelnak A., Fehrenbacher L., Jakobsen E.H, Curtit E., Boyle F., Brix E.H, Brenner A.J, Ferrario C., Munoz-Mateu M., Arkenau T., Gelmon K.A, Cameron D., Curigliano G., DeBusk K., Ramos J., An X., Wardley A.M
JournalANNALS OF ONCOLOGY
Volume31
PaginationS349-S350
Date PublishedSEP
Type of ArticleMeeting Abstract
ISSN0923-7534
DOI10.1016/j.annonc.2020.08.377